Cerebrolysin
- Generic Name
- Cerebrolysin
- Drug Type
- Biotech
- CAS Number
- 12656-61-0
- Unique Ingredient Identifier
- 37KZM6S21G
Overview
No overview information available.
Background
No background information available.
Indication
用于脑血管疾病及脑动脉硬化、脑外伤或脑卒中后遗症、大脑发育不全、老年性痴呆以及记忆力减退者。
Associated Conditions
- Alzheimer's Disease (AD)
- Cerebrovascular Diseases
- Craniocerebral Injuries
- Stroke
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/11/06 | Not Applicable | ENROLLING_BY_INVITATION | |||
2024/07/08 | Early Phase 1 | Not yet recruiting | University Hospital "Sestre Milosrdnice" | ||
2024/04/01 | Early Phase 1 | Not yet recruiting | Chang Gung Memorial Hospital | ||
2024/02/22 | Phase 4 | Recruiting | Hospital Universitario Dr. Jose E. Gonzalez | ||
2024/01/17 | Phase 4 | Completed | Sherifa Ahmed Hamed | ||
2023/10/06 | Not Applicable | Recruiting | |||
2023/09/25 | Phase 3 | Recruiting | |||
2023/05/18 | Not Applicable | ENROLLING_BY_INVITATION | |||
2023/04/20 | Phase 1 | Recruiting | |||
2023/04/11 | N/A | Completed | Pomeranian Medical University Szczecin |
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|
No FDA products found
No FDA products found for this drug
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|
No EMA products found
No EMA products found for this drug
Singapore Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
|---|
No Singapore products found
No Singapore products found for this drug
China Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|---|---|---|---|---|---|---|---|---|
Cerebroprotein Hydrolysate for Injection（Ⅰ） | 国药准字H20051738 | 注射剂 | 安谱福 | 60 mg(以总氮计) | Chemical Drug | Approved | 2020/08/28 | Domestic | |
Cerebroprotein Hydrolysate for Injection（Ⅰ） | 国药准字H20051737 | 注射剂 | 安谱福 | 30 mg(以总氮计) | Chemical Drug | Approved | 2020/08/28 | Domestic | |
Cerebroprotein Hydrolysate Oral Solution | 国药准字H22025712 | 口服溶液剂 | N/A | 10ml:50mg | Chemical Drug | Approved | 2020/03/19 | Domestic | |
Cerebroprotein Hydrolysate for Injection（Ⅱ） | 国药准字H20051230 | 注射剂 | 舒瑞泰 | 30.50mg(以总氮计) | Chemical Drug | Approved | 2020/04/15 | Domestic | |
Cerebroprotein Hydrolysate for Injection（III） | 国药准字H20041581 | 注射剂 | N/A | 60mg | Chemical Drug | Approved | 2020/09/05 | Domestic | |
Cerebroprotein Hydrolysate for Injection(Ⅲ) | 国药准字H20052183 | 注射剂 | N/A | 30mg(以总N计) | Chemical Drug | Approved | 2020/08/25 | Domestic | |
Cerebroprotein Hydrolysate for Injection（III） | 国药准字H20041580 | 注射剂 | N/A | 30mg | Chemical Drug | Approved | 2020/09/05 | Domestic | |
Cerebroprotein Hydrolysate for Injection（Ⅲ） | 国药准字H20051032 | 注射剂 | 瑞奇妥芬 | 以总氮计60mg | Chemical Drug | Approved | 2023/05/26 | Domestic | |
Cerebroprotein Hydrolysate for Injection（Ⅲ） | 国药准字H20051010 | 注射剂 | 宁泽欣 | 30mg(以总氮计) | Chemical Drug | Approved | 2020/05/19 | Domestic | |
Cerebroprotein Hydrolysate for Injection（Ⅲ） | 国药准字H20051443 | 注射剂(冻干粉针剂) | 韦司平 | 30mg(以总氮计) | Chemical Drug | Approved | 2017/08/18 | Domestic |
Australia Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|
No Australia products found
No Australia products found for this drug
© Copyright 2025. All Rights Reserved by MedPath